Providence Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.6M | Buy |
18,737
+4,531
| +32% | +$1.84M | 1.39% | 19 |
|
|
2025
Q1 | $7.07M | Buy |
14,206
+320
| +2% | +$159K | 1.47% | 18 |
|
|
2024
Q4 | $7.22M | Buy |
13,886
+134
| +1% | +$69.7K | 1.47% | 14 |
|
|
2024
Q3 | $8.51M | Buy |
13,752
+3,296
| +32% | +$2.04M | 1.69% | 12 |
|
|
2024
Q2 | $5.78M | Buy |
10,456
+103
| +1% | +$57K | 1.26% | 31 |
|
|
2024
Q1 | $6.02M | Buy |
10,353
+161
| +2% | +$93.6K | 1.31% | 27 |
|
|
2023
Q4 | $5.41M | Buy |
10,192
+6
| +0.1% | +$3.19K | 1.3% | 26 |
|
|
2023
Q3 | $5.16M | Sell |
10,186
-36
| -0.4% | -$18.2K | 1.35% | 20 |
|
|
2023
Q2 | $5.33M | Buy |
10,222
+86
| +0.8% | +$44.9K | 1.35% | 25 |
|
|
2023
Q1 | $5.84M | Buy |
10,136
+691
| +7% | +$398K | 1.54% | 11 |
|
|
2022
Q4 | $5.2M | Buy |
9,445
+47
| +0.5% | +$25.9K | 1.4% | 20 |
|
|
2022
Q3 | $4.77M | Sell |
9,398
-1,361
| -13% | -$691K | 1.43% | 13 |
|
|
2022
Q2 | $5.85M | Buy |
10,759
+186
| +2% | +$101K | 1.7% | 9 |
|
|
2022
Q1 | $6.24M | Buy |
10,573
+760
| +8% | +$449K | 1.53% | 10 |
|
|
2021
Q4 | $6.55M | Buy |
9,813
+417
| +4% | +$278K | 1.8% | 13 |
|
|
2021
Q3 | $5.37M | Buy |
9,396
+489
| +5% | +$279K | 1.67% | 16 |
|
|
2021
Q2 | $4.49M | Buy |
8,907
+195
| +2% | +$98.4K | 1.45% | 23 |
|
|
2021
Q1 | $3.98M | Buy |
8,712
+366
| +4% | +$167K | 1.45% | 27 |
|
|
2020
Q4 | $3.89M | Buy |
8,346
+597
| +8% | +$278K | 1.59% | 22 |
|
|
2020
Q3 | $3.42M | Sell |
7,749
-89
| -1% | -$39.3K | 1.8% | 13 |
|
|
2020
Q2 | $2.84M | Sell |
7,838
-21
| -0.3% | -$7.61K | 1.61% | 26 |
|
|
2020
Q1 | $2.23M | Buy |
7,859
+817
| +12% | +$232K | 1.34% | 30 |
|
|
2019
Q4 | $2.29M | Buy |
7,042
+157
| +2% | +$51K | 1.23% | 37 |
|
|
2019
Q3 | $2.01M | Buy |
6,885
+146
| +2% | +$42.5K | 1.18% | 42 |
|
|
2019
Q2 | $1.98M | Sell |
6,739
-3,400
| -34% | -$998K | 1.17% | 42 |
|
|
2019
Q1 | $2.78M | Buy |
10,139
+170
| +2% | +$46.5K | 1.75% | 9 |
|
|
2018
Q4 | $2.23M | Buy |
9,969
+526
| +6% | +$118K | 1.53% | 12 |
|
|
2018
Q3 | $2.31M | Buy |
9,443
+385
| +4% | +$94K | 1.5% | 21 |
|
|
2018
Q2 | $1.88M | Buy |
9,058
+411
| +5% | +$85.1K | 1.32% | 27 |
|
|
2018
Q1 | $1.79M | Buy |
8,647
+338
| +4% | +$69.8K | 1.34% | 30 |
|
|
2017
Q4 | $1.58M | Buy |
+8,309
| New | +$1.58M | 1.22% | 35 |
|